(Q48951806)

17 February 2018

title

The relationship between clinical and pathological variables in Richardson's syndrome. (English)

1 reference

17 February 2018

author

Glenda Halliday

5

1 reference

17 February 2018

John Hodges

2

object named as

John R Hodges

1 reference

17 February 2018

John H Xuereb

4

object named as

John H Xuereb

1 reference

17 February 2018

author name string

Emma C Schofield

1

1 reference

17 February 2018

Thomas H Bak

3

1 reference

17 February 2018

publication date

12 August 2011

1 reference

17 February 2018

published in

Journal of Neurology

1 reference

17 February 2018

volume

259

1 reference

17 February 2018

issue

3

1 reference

17 February 2018

page(s)

482-490

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-011-6205-8

exact match

0 references

cites work

The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Regional frontal injuries cause distinct impairments in cognitive control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Visuospatial functions in atypical parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neurone disease-dementia-aphasia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Progressive supranuclear palsy with dementia: cortical pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Monitoring cognitive changes: psychometric properties of six cognitive tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Control of goal-directed and stimulus-driven attention in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

The neural basis of semantic memory: evidence from semantic dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Neuropathology of variants of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Emotion recognition in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

A clinical rating scale for progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Neurons in anterior cingulate cortex multiplex information about reward and action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Voxel-based morphometry in autopsy proven PSP and CBD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

The cerebral cortex is damaged in chronic alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Spatial working memory and spatial attention rely on common neural processes in the intraparietal sulcus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6205-8

Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration.

21 January 2018

1 reference

12 December 2020

Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies

1 reference

12 December 2020

Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

1 reference

12 December 2020

Attention systems and the organization of the human parietal cortex.

1 reference

12 December 2020

SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

1 reference

12 December 2020

Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy

1 reference

12 December 2020

Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy

1 reference

12 December 2020

The Addenbrooke's cognitive examination (ACE) in the differential diagnosis of early dementias versus affective disorder.

1 reference

12 December 2020

Evidence for impaired sentence comprehension in early Alzheimer's disease.

1 reference

12 December 2020

Cognitive disturbances in progressive supranuclear palsy.

1 reference

12 December 2020

10.1007/S00415-011-6205-8

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

21837549

1 reference

17 February 2018